WSC
TTRX

Wellington Shields & Co’s Turn Therapeutics TTRX Stock Holding History

Wellington Shields & Co’s Portfolio TTRX Stock Details TTRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$210K Hold
65,732
– – 0.05% 236
2025
Q4 		$259K Buy
+65,732
New +$274K 0.06% 213

Other funds holding TTRX

DI
DDFG Inc Thousand Oaks, California $464M AUM 16.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TS
Tamar Securities Woodland Hills, California $934M AUM 26.74% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
RW
RVW Wealth Los Angeles, California $1.52B AUM 23.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MMA
Miracle Mile Advisors Los Angeles, California $7.29B AUM 16.22% 1-Year Est. Return

Wellington Shields & Co's TTRX Position: Q1 2026 in Review

Wellington Shields & Co held its Turn Therapeutics (TTRX) position steady in Q1 2026 at 65,732 shares worth $210K. The position accounts for 0.05% of the portfolio, ranked #236.

Wellington Shields & Co first reported a position in TTRX in Q4 2025 and has held it in 2 quarters since. The position peaked at $259K in Q4 2025. 20 funds tracked by Wall St. Rank hold TTRX as of Q1 2026.

  • Wellington Shields & Co held 65,732 shares of Turn Therapeutics worth $210K as of Q1 2026.
  • Wellington Shields & Co left its Turn Therapeutics share count unchanged in Q1 2026.
  • Turn Therapeutics made up 0.05% of Wellington Shields & Co's portfolio in Q1 2026, its #236 holding.
  • Wellington Shields & Co first reported a position in Turn Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Wellington Shields & Co's Turn Therapeutics position peaked at $259K in Q4 2025.
  • 20 funds tracked by Wall St. Rank held Turn Therapeutics as of Q1 2026.

Based on Wellington Shields & Co's 13F filing for Q1 2026, filed 4 May 2026.